Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer

Exclusion Criteria

• •Psychiatric history including past or current psychotic spectrum disorders (schizophrenia, bipolar disorder, major depressive disorder, dementia, schizoaffective disorder)
• •Brain injury (e.g., stroke, heart attack, aneurysm, tumor, concussion, head trauma)
• •Brain disease
• •History of brain irradiation or surgery
• •Current or past disease/disorder of the central nervous system or medical condition affecting cognitive functioning (e.g., chronic migraine, epilepsy or history of seizures, encephalitis, meningitis, multiple sclerosis, thyroid condition, Parkinson's, Alzheimer's, Huntington's disease)
• •Active diagnosis of autoimmune or inflammatory disorder (e.g., systemic lupus erythematosus, rheumatoid arthritis, vasculitis, insulin-dependent diabetes, Crohn's disease, uncontrolled allergic reaction or asthma)
• •History of other cancer, except for basal cell carcinoma
• •Development of a second primary malignancy during the study
• •Drug or alcohol abuse (i.e., more than 7 drinks per week)
• •Chronic use of oral steroid medication
• •Former (prior to early-stage breast cancer) intrathecal therapy, radiation therapy, chemotherapy, or any neoadjuvant chemotherapy
• •Acquired or developmental speech, language, or learning disorders (e.g., aphasia, dyslexia, dysgraphia, auditory processing disorder, autism, developmental delay)
• •Hormone replacement therapy, excluding vaginal estrogen